1. Home
  2. NLSP vs ZAPP Comparison

NLSP vs ZAPP Comparison

Compare NLSP & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
    SELLHOLDBUYas of 11 hours ago
  • ZAPP
    SELLHOLDBUYas of 11 hours ago
  • Stock Information
  • Founded
  • NLSP 2015
  • ZAPP 2017
  • Country
  • NLSP Switzerland
  • ZAPP Thailand
  • Employees
  • NLSP N/A
  • ZAPP N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • ZAPP Motor Vehicles
  • Sector
  • NLSP Health Care
  • ZAPP Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • ZAPP Nasdaq
  • Market Cap
  • NLSP 6.9M
  • ZAPP 7.0M
  • IPO Year
  • NLSP 2021
  • ZAPP N/A
  • Fundamental
  • Price
  • NLSP $1.48
  • ZAPP $0.70
  • Analyst Decision
  • NLSP
  • ZAPP
  • Analyst Count
  • NLSP 0
  • ZAPP 0
  • Target Price
  • NLSP N/A
  • ZAPP N/A
  • AVG Volume (30 Days)
  • NLSP 27.3K
  • ZAPP 155.4K
  • Earning Date
  • NLSP 05-14-2025
  • ZAPP 01-31-2025
  • Dividend Yield
  • NLSP N/A
  • ZAPP N/A
  • EPS Growth
  • NLSP N/A
  • ZAPP N/A
  • EPS
  • NLSP N/A
  • ZAPP N/A
  • Revenue
  • NLSP N/A
  • ZAPP $17,440.00
  • Revenue This Year
  • NLSP N/A
  • ZAPP $67,159.17
  • Revenue Next Year
  • NLSP N/A
  • ZAPP $1,149.53
  • P/E Ratio
  • NLSP N/A
  • ZAPP N/A
  • Revenue Growth
  • NLSP N/A
  • ZAPP N/A
  • 52 Week Low
  • NLSP $1.30
  • ZAPP $0.60
  • 52 Week High
  • NLSP $18.40
  • ZAPP $19.10
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 42.03
  • ZAPP 36.22
  • Support Level
  • NLSP $1.45
  • ZAPP $0.66
  • Resistance Level
  • NLSP $1.60
  • ZAPP $0.92
  • Average True Range (ATR)
  • NLSP 0.11
  • ZAPP 0.08
  • MACD
  • NLSP 0.02
  • ZAPP -0.02
  • Stochastic Oscillator
  • NLSP 52.29
  • ZAPP 22.70

Stock Price Comparison Chart: NLSP vs ZAPP

NLSP
ZAPP
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April024681012141618NLSP VS ZAPP

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About ZAPP Zapp Electric Vehicles Group Limited

Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories. Companies founders are automotive professionals from all over the world who share a commitment to sustainability, a long passion for electric vehicles, motorcycles, and believe in the choice of personal urban mobility. The company operates in Cayman Islands, Europe, Thailand. Maximum of revenue is from Thailand.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use